Analysis of clinical stage T2 prostate cancer: Do current subclassifications represent an improvement? Academic Article uri icon

Overview

MeSH Major

  • Prostatic Neoplasms

abstract

  • The 1992 American Joint Committee on Cancer system is superior to the 1997 system, and the former adds prognostic information to a model containing pretreatment PSA and Gleason sum. These results suggest that 1992 T2 subclassification derived from palpable findings improves prognostication over the 1997 subclassification.

publication date

  • April 15, 2002

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2002.08.123

PubMed ID

  • 11956261

Additional Document Info

start page

  • 2025

end page

  • 30

volume

  • 20

number

  • 8